Similarly, hepatic LXRα phosphorylation in NAFLD mice was suppressed, while metformin dose-dependently enhanced LXRα phosphorylation of ob/ob mice (Figure 1F). The gene discussed is NR1H3; the disease is metabolic dysfunction-associated steatotic liver disease.